Founded with a mission to revolutionize medical imaging, Clarix Imaging focuses on developing advanced imaging devices that enhance the accuracy of disease diagnosis and improve patient care. Their flagship product, the VSI-360™ Intraoperative Volumetric Specimen Imaging System, is specialized for breast surgical oncology. This device provides true 3D image reconstruction of lumpectomy specimens, allowing surgeons to visualize specimen margins with unprecedented clarity, thus ensuring more precise surgical outcomes.
Clarix Imaging has garnered attention from notable figures in the medical and tech industries, securing investments from prominent venture capital firms. The company has achieved significant milestones, including successful clinical trials and regulatory approvals for their VSI-360™ system. Their innovative approach has made a substantial impact on the field of surgical oncology, improving diagnostic accuracy and patient outcomes in breast cancer surgeries.
